Indacaterol
RxNorm 1114326
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1114326 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: indacaterol.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
IN
Ingredient (IN):
Indacaterol
(Atom ID: 3744668)
PT
Designated preferred name (PT):
Indacaterol
(Atom ID: 6389615)
FN
Full form of descriptor (FN):
Indacaterol (substance)
(Atom ID: 6389618)
PT
Designated preferred name (PT):
Indacaterol-containing product
(Atom ID: 10804974)
FN
Full form of descriptor (FN):
Product containing indacaterol (medicinal product)
(Atom ID: 9724614)
Patient Education
Indacaterol Oral Inhalation
Indacaterol inhalation is used to control wheezing, shortness of breath, coughing, and chest tightness caused by chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways, which includes chronic bronchitis and emphysema). Indacaterol is in a class of medications called long-acting beta agonists (LABAs). It works by relaxing and opening air passages in the lungs, making it easier to breathe.
[Learn More]
* Please review the disclaimer below.